01 7Adcal-D3
Main Therapeutic Indication : Musculoskeletal
Currency : USD
2020 Revenue in Millions : 30
2019 Revenue in Millions : 28
Growth (%) : 7
Main Therapeutic Indication : Musculoskeletal
Currency : USD
2021 Revenue in Millions : 25
2020 Revenue in Millions : 30
Growth (%) : -6
Main Therapeutic Indication : Musculoskeletal
Currency : USD
2022 Revenue in Millions : 23
2021 Revenue in Millions : 25
Growth (%) : -10
Main Therapeutic Indication : Musculoskeletal
Currency : USD
2023 Revenue in Millions : 11
2022 Revenue in Millions : 23
Growth (%) : -43
Calcium Carbonate, Cholecalciferol
Main Therapeutic Indication : Bone and Joint Diseases
Currency : USD
2017 Revenue in Millions : 35
2016 Revenue in Millions : 37
Growth (%) : -8
Calcium Carbonate, Cholecalciferol
Main Therapeutic Indication : Bone And Joint Diseases
Currency : USD
2018 Revenue in Millions : 32
2017 Revenue in Millions : 32
Growth (%) : -3%
Main Therapeutic Indication : Musculoskeletal
Currency : USD
2019 Revenue in Millions : 28
2018 Revenue in Millions : 33
Growth (%) : -14
LOOKING FOR A SUPPLIER?